Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen-specific antibody mediation

Annals of Neurology

Volumn 46, Issue 2, 1999, Pages 144-160

  Raine, Cedric S ^a   Cannella, Barbara ^a   Hauser, Stephen L ^b   Genain, Claude P ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLYCOPROTEIN; GOLD; IMMUNOGLOBULIN G; MYELIN; MYELIN BASIC PROTEIN; MYELIN PROTEIN;

ADULT; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CASE REPORT; CONTROLLED STUDY; DEMYELINATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MONKEY; MULTIPLE SCLEROSIS; MYELIN SHEATH; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANIMALS; ANTIBODY SPECIFICITY; AUTOIMMUNITY; BRAIN; CALLITHRIX; DEMYELINATING DISEASES; ENCEPHALOMYELITIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON; MULTIPLE SCLEROSIS;

EID: 0032839687     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199908)46:2<144::AID-ANA3>3.0.CO;2-K     Document Type: Article

References (62)

1. Massacesi L, Genain CP, Lee-Parritz D, et al. Active and passively induced autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. Ann Neurol 1995;47:519-530
2. Genain CP, Nguyen MH, Pearl R, et al. Antibody facilitation of multiple sclerosis-like lesions in a non human primate. J Clin Invest 1995;96:2966-2974
3. Genain CP, Hauser SL. Creation of a model for multiple sclerosis in Callithrix jacchus marmosets. J Mol Med 1997;75:187-197
4. Hart BA, Bauer J, Muller H-J, et al. Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis. Am J Pathol 1998;153:649-663
5. Rivers TM, Schwentker FF. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J Exp Med 1935;61:689-702
6. Ferraro A, Cazzullo CL. Chronic experimental allergic encephalomyelitis in monkeys. J Neuropathol Exp Neurol 1948;7: 235-260
7. Ravkina L, Rogova Y, Lazarenko L. Chronic experimental allergic encephalomyelitis in rhesus monkeys and its modification by treatment. J Neurol Sci 1978;38:281-293
8. Alvord EC, Shaw CM, Hruby S. Myelin basic protein treatment of experimental allergic encephalomyelitis in monkeys. Ann Neurol 1979;6:467-473
9. Fidle EJ, Raine CS. Experimental allergic encephalomyelitis in the rhesus monkey - an electron microscope study. J Neurol Sci 1969;8:397-411
10. Kibler RF, Re PK, McKneally S, Shapira R. Biological activity of an encephalitogenic fragment in the monkey. J Biol Chem 1972;2:969-972
11. Eylar EH, Brostoff S, Jackson J, Carter H. Allergic encephalomyelitis in monkeys induced by a peptide from the A1 protein. Proc Natl Acad Sci USA 1972;69:617-619
12. Karkhanis YD, Carlo DJ, Brostoff SW, Eylar EH. Allergic encephalomyelitis. J Biol Chem 1975;5:1718-1722
13. Genain CP, Abel K, Belmar N, et al. Late complications of immune deviation therapy in a non human primate. Science 1996;274:2054-2057
14. Lee SC, Moore GRW, Golenwsky G, Raine CS. A role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study. J Neuropathol Exp Neurol 1990;49:122-136
15. Raine CS, Lee SC, Scheinberg LC, et al. Adhesion molecules on endothelial cells in the central nervous system; an emerging area in the neuroimmunology of multiple sclerosis. Clin Immunol Immunopathol 1990;57:173-187
16. Katz D, Taubenberger JK, Cannella B, et al. Correlation between MRI findings and lesion development in chronic active multiple sclerosis. Ann Neurol 1993;34:661-669
17. Genain C, Belmar N, Diaz-Villoslada P, Hauser S. Fine specificities of T cell and B cell responses to myelin/oligodendrocyte glycoprotein in common marmosets. J Neuroimmunol 1998; 90:34 (Abstract)
18. Genain CP, Lee-Parritz D, Nguyen MH, et al. In healthy primates, circulating autoreactive T cells mediate autoimmune disease. J Clin Invest 1994;94:1339-1345
19. Wücherpfennig KW, Sette A, Southwood S, et al. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med 1994;179:279-290
20. Genain CP, Cannella B, Hauser SL, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 1999;5:170-175
21. Anderson AI, Anderson ND. Lymphocyte emigration from high endothelial venules in rat lymph nodes. Immunology 1976;31:731-748
22. Raine CS. Demyelinating diseases. In: Davis RL, Robertson DM, eds. Textbook of neuropathology. 3rd ed. Baltimore: Williams and Wilkins, 1997:243-287
23. Prineas JW, McDonald WI. Demyelinating diseases. In: Graham DI, Lantos PL, eds. Greenfield's neuropathology. 6th ed. London: Arnold, 1997:813-896
24. 14C-labeled cells during acute, chronic and relapsing experimental allergic encephalomyelitis. Lab Invest 1990;63:162-170
25. Raine CS, Cannella B, Duijvestijn AM, Cross AH. Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Lab Invest 1990;63: 476-489
26. Prineas JW, Connell F. The fine structure of chronically active multiple sclerosis plaques. Neurology 1978;28:68-75
27. Epstein LG, Prineas JW, Raine CS. Attachment of myelin to coated pits on macrophages in experimental allergic encephalomyelitis. J Neurol Sci 1983;61:341-348
28. Moore GRW, Raine CS. Immunogold localization and analysis of IgG in acute experimental allergic encephalomyelitis. Lab Invest 1988;59:641-648
29. Raine CS. Biology of disease. The analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 1984;50:608-635
30. Bonetti B, Raine CS. Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ do not undergo apoptosis. Ann Neurol 1997;42:74-82
31. Lucchinetti CF, Brück W, Rodriguez M, Lassman H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity of pathogenesis. Brain Pathol 1996;6:259-274
32. Marburg O. Die sogenannte "akute multiple sklerose" (encephalomyelitis periaxialis scleroticans). Jahrb Psychiatr Neurol 1906;27:211-312
33. Wu E, Raine CS. Multiple sclerosis: interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, non-demyelinating conditions. Lab Invest 1992;67: 88-99
34. Brosnan CF, Raine CS. Mechanisms of immune injury in multiple sclerosis. Brain Pathol 1996;6:243-257
35. Lumsden CE. The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology, vol 9. Amsterdam: North Holland, 1970:271
36. Kirk J. Pseudoviral hollow-cored vesicles in multiple sclerosis brain. Acta Neuropathol (Berl) 1979;48:63-66
37. Lampert PW, Carpenter S. Electron microscopic studies on the vascular permeability and the mechanisms of demyelination in experimental allergic encephalomyelitis. J Neuropathol Exp Neurol 1965;24:11-24
38. Raine CS, Snyder DH, Valsamis MP, Stone SH. Chronic experimental allergic encephalomyelitis in inbred guinea pigs - an ultrastructural study. Lab Invest 1974;31:369-380
39. Bornstein MB, Appel SH. The application of tissue culture to the study of experimental "allergic" encephalomyelitis. I, Patterns of demyelination. J Neuropathol Exp Neurol 1996;20: 141-157
40. Bornstein MB. A tissue culture approach to demyelinative disorders. National Cancer Institute monograph no. 11. Bethesda, MD: National Cancer Institute, 1963:197-214
41. Appel SH, Bornstein MB. The application of tissue culture to the study of experimental "allergic" encephalomyelitis. II, Serum factors responsible for demyelination. J Exp Med 1964; 119:303-312
42. Raine CS, Bornstein MB. Experimental allergic encephalomyelitis: an ultrastructural study of experimental demyelination in vitro. J Neuropathol Exp Neurol 1970;29:177-191
43. Raine CS, Hummelgard A, Swanson E, Bornstein MB. Multiple sclerosis: serum-induced demyelination in vitro. A light and electron microscope study. J Neurol Sci 1973;20:127-148
44. Raine CS, Johnson AB, Marcus D, et al. Demyelination in vitro: absorption studies demonstrate that galactocerebroside is a major target. J Neurol Sci 1981;52:117-131
45. Seil FJ, Falk GA, Kies MW, Alvord EC. The in vitro demyelinating activity of sera from guinea pigs sensitized with whole CNS and with purified encephalitogen. Exp Neurol 1968;22: 545-555
46. Brosnan CF, Traugott U, Raine CS. Analysis of humoral and cellular events and the role of lipid haptens during CNS demyelination. Acta Neuropathol (Berl) 1983;60(Suppl 9):59-70
47. Raine CS. Multiple sclerosis: a pivotal role for the T cell in lesion development. Neuropathol Appl Neurobiol 1991;17: 265-274
48. Reder AT, Arnason BGW. Immunology of multiple sclerosis. In: Koetsier JC, ed. Handbook of clinical neurology, vol 47: demyelinating diseases. Amsterdam: Elsevier, 1985:337-395
49. Martin R, McFarland HF. Immunology of multiple sclerosis and experimental allergic encephalomyelitis. In: Raine CS, McFarland HF, Tourtellotte WW, eds. Multiple sclerosis: clinical and pathogenetic basis. London: Chapman and Hall, 1997: 221-242
50. Birnbaum G, Antel J. Immunology of multiple sclerosis. In: Antel J, Birnbaum G, Hartung H-P, eds. Clinical neuroimmunology. Oxford: Blackwell's, 1998:105-115
51. Selmaj KW. The role of cytokines in inflammatory conditions of the central nervous system. Semin Neurosci 1992;4:221-229
52. Ruddle NH, Bergman CM, McGrath ML, et al. An antibody to lymphotoxin and tumor necrosis factor prevents experimental allergic encephalomyelitis. J Exp Med 1990;172:1193-1200
53. Selmaj K, Raine CS, Cross AH. Anti-cytokine therapy abrogates autoimmune demyelination. Ann Neurol 1991;30:694-700
54. Genain CP, Roberts T, Davis RL, et al. Prevention of autoimmune demyelination by a cAMP-specific phosphodiesterase inhibitor. Proc Natl Acad Sci USA 1995;92:3601-3605
55. Hjelmstrom P, Juedes A, Fjell J, Ruddle N. Cutting edge: B cell deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J Immunol 1998;161:4480-4483
56. Selmaj K, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988;23: 339-346
57. Aleu FB, Katzman R, Terry RD. Fine structure and electrolyte analyses of cerebral edema induced by alkyl tin intoxication. J Neuropathol Exp Neurol 1963;22:403-413
58. Dal Canto M, Wisniewski HM, Johnson AB, et al. Vesicular disruption of myelin in autoimmune demyelination. J Neurol Sci 1975;24:313-319
59. Wisniewski H, Raine CS. An ultrastructural study of experimental demyelination and remyelination. V. Central and peripheral nervous system lesions caused by diphtheria toxin. Lab Invest 1971;25:73-80
60. Kerlero de Rosbo N, Milo R, Lees MB, et al. Reactivity to myelin proteins in multiple sclerosis. J Clin Invest 1993;92: 2602-2608
61. Warren K, Catz I, Johnson E, Mielke B. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis. Ann Neurol 1994;35:280-289
62. Wallstrom E, Khademi M, Andersson M, et al. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis. Eur J Immunol 1998;28:3329-3335